Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study

Z. Bakouny, C. Labaki, S. Bhalla, A. L. Schmidt, J. A. Steinharter, J. Cocco, D. A. Tremblay, M. M. Awad, A. Kessler, R. I. Haddad, M. Evans, F. Busser, M. Wotman, C. R. Curran, B. S. Zimmerman, G. Bouchard, T. Jun, P. V. Nuzzo, Q. Qin, L. HirschJ. Feld, K. M. Kelleher, D. Seidman, H. Huang, H. M. Anderson-Keightly, T. El Zarif, S. Abou Alaiwi, C. Champagne, T. D. Rosenbloom, P. S. Stewart, B. E. Johnson, Q. Trinh, S. M. Tolaney, M. D. Galsky, T. K. Choueiri, D. B. Doroshow

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Sort by
Weight
Alphabetically

Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study

Fingerprint

Medicine & Life Sciences